GB Sciences appoints Dr. Small-Howard as CEO, CFO, Chairman after John Poss's death

GB SCIENCES INC

John Poss passed away on July 10, 2024; he led GB Sciences as CEO and Chairman since 2015.
Dr. Andrea Small-Howard promoted to CEO, CFO, and Chairman under a pre-established succession plan.
Dr. Small-Howard previously served as President for three years, overseeing day-to-day operations.
She is a founding board member and the architect of the company's cannabinoid medicine strategy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Andrea Small-Howard

Chief Executive Officer, Chief Financial Officer, and Chairman

GB SCIENCES INC

Effective: 2024-07-10
Filed: July 16, 2024, 7:59 PM ET

She was promoted to CEO, CFO and Chairman of the Board as a part of their succession plan, which was created due to the failing health of Mr. John Poss.

Departed

John Poss

Chief Executive Officer and Chairman

GB SCIENCES INC

Effective: 2024-07-10
Successor: Dr. Andrea Small-Howard
Filed: July 16, 2024, 7:59 PM ET

Mr. Poss had battled through serious health issues and had served the company very well since 2015. Fortunately, Mr. Poss had spent years preparing Dr. Small-Howard for her expanded role as CEO, CFO and Chairman, which roles fell to her upon the passing of Mr. Poss on July 10, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Andrea Small-Howard was appointed as Chief Executive Officer, Chief Financial Officer, and Chairman at GB SCIENCES INC.

Action: promoted
Role: Chief Executive Officer, Chief Financial Officer, and Chairman

Exact text from the filing

She was promoted to CEO, CFO and Chairman of the Board as a part of their succession plan, which was created due to the failing health of Mr. John Poss.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Poss departed as Chief Executive Officer and Chairman at GB SCIENCES INC.

Action: passed away
Role: Chief Executive Officer and Chairman

Exact text from the filing

Mr. Poss had battled through serious health issues and had served the company very well since 2015. Fortunately, Mr. Poss had spent years preparing Dr. Small-Howard for her expanded role as CEO, CFO and Chairman, which roles fell to her upon the passing of Mr. Poss on July 10, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001437749-24-022794

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.